Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Dimethyl fumarate for treating relapsing multiple sclerosis.
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
Involvement of Notch1 inhibition in serum-stimulated glia and oligodendrocyte differentiation from human mesenchymal stem cells.
Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
Cerebral adenosine A1 receptors are upregulated in rodent encephalitis.
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.
There is still a role for the blink reflex in the diagnosis and follow-up of multiple sclerosis.
Fiber-Optic Bronchoscopy and Volume-Cycled Mouthpiece Ventilation for a Patient with Multiple Sclerosis and Ventilatory Failure.
Association of interleukin-1 gene cluster polymorphisms and haplotypes with multiple sclerosis in an Iranian population.
Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Associations of Systemic Diseases with Intermediate Uveitis.
Pages
« first
‹ previous
…
559
560
561
562
563
564
565
566
567
…
next ›
last »